Bluebird Ventures — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Kriya Therapeutics is a biopharmaceutical company that develops and manufactures one-time gene therapies aimed at treating prevalent chronic diseases.
BiotechHealthtechMorrisville, US
Shankar Ramaswamy(Co-Founder, Chairman & CEO)inRoger Jeffs(Co-Founder & Vice Chairman)Fraser Wright(Scientific Co-Founder & Chief Gene Therapy Officer)inShankar Ramaswamy, M.D.(Founder)inMichele Stone(Chief Scientific Officer)Katherine Eade(Chief Legal Officer)
PartnerJeffrey Bird· solo GP
Co-investorsPatient Square CapitalPremji InvestAmplo VenturesForesite CapitalJDRF T1D FundNarya Capital+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.